1. Home
  2. DNLI vs HMN Comparison

DNLI vs HMN Comparison

Compare DNLI & HMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • HMN
  • Stock Information
  • Founded
  • DNLI 2013
  • HMN 1945
  • Country
  • DNLI United States
  • HMN United States
  • Employees
  • DNLI N/A
  • HMN N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • HMN Property-Casualty Insurers
  • Sector
  • DNLI Health Care
  • HMN Finance
  • Exchange
  • DNLI Nasdaq
  • HMN Nasdaq
  • Market Cap
  • DNLI 2.1B
  • HMN 1.8B
  • IPO Year
  • DNLI 2017
  • HMN 1991
  • Fundamental
  • Price
  • DNLI $14.19
  • HMN $47.60
  • Analyst Decision
  • DNLI Strong Buy
  • HMN Buy
  • Analyst Count
  • DNLI 16
  • HMN 5
  • Target Price
  • DNLI $33.62
  • HMN $46.75
  • AVG Volume (30 Days)
  • DNLI 2.0M
  • HMN 190.4K
  • Earning Date
  • DNLI 11-05-2025
  • HMN 11-03-2025
  • Dividend Yield
  • DNLI N/A
  • HMN 2.94%
  • EPS Growth
  • DNLI N/A
  • HMN 71.62
  • EPS
  • DNLI N/A
  • HMN 3.38
  • Revenue
  • DNLI N/A
  • HMN $1,649,200,000.00
  • Revenue This Year
  • DNLI N/A
  • HMN $7.38
  • Revenue Next Year
  • DNLI $802.87
  • HMN $6.25
  • P/E Ratio
  • DNLI N/A
  • HMN $14.08
  • Revenue Growth
  • DNLI N/A
  • HMN 6.01
  • 52 Week Low
  • DNLI $10.57
  • HMN $33.05
  • 52 Week High
  • DNLI $33.33
  • HMN $47.81
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 41.95
  • HMN 72.50
  • Support Level
  • DNLI $14.63
  • HMN $45.97
  • Resistance Level
  • DNLI $15.69
  • HMN $46.69
  • Average True Range (ATR)
  • DNLI 0.68
  • HMN 0.76
  • MACD
  • DNLI -0.14
  • HMN 0.05
  • Stochastic Oscillator
  • DNLI 0.99
  • HMN 93.25

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About HMN Horace Mann Educators Corporation

Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are 403(b) tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.

Share on Social Networks: